市場調査レポート

商品コード

1705119

麻酔薬の世界市場：薬剤クラス別、投与経路別、用途別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Anesthesia Drugs Market Assessment, By Drugs Class, By Route of Administration, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日: 2025年04月16日
発行: Market Xcel - Markets and Data
ページ情報: 英文 227 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 646,065円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 818,349円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,177,274円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の麻酔薬の市場規模は、2025年～2032年の予測期間中に4.73％のCAGRで拡大し、2024年の77億1,000万米ドルから2032年には111億6,000万米ドルに成長すると予測されています。同市場の成長は、慢性疾患患者の増加、外科手術への依存度の増加、高齢化人口の拡大に起因しています。世界保健機関（WHO）の推定によると、心血管疾患は死因の第一位であり、毎年約1,790万人の命を奪っています。

選択的な美容整形手術から複雑な臓器移植に至るまで、ほとんどすべての手術では、手術中の患者の安全性と快適性を維持するために麻酔が必要です。慢性疾患や生活習慣病が増加の一途をたどる中、手術件数は今後数年間で大幅に増加すると予想されます。世界中の高齢者人口がこの動向をさらに後押ししています。高齢患者は、変形性関節症、白内障、心血管障害などの退行性疾患のために外科的治療を必要とすることが多いです。

病院や外来手術センターでは、入院手術と日帰り手術の両方が増加しており、全身麻酔薬、局所麻酔薬、局所麻酔薬の需要を支えています。統合麻酔デリバリー・システムやリアルタイムの患者モニタリングを含む技術の進歩により、手術中の麻酔薬デリバリーの精度と安全性が向上しています。

当レポートでは、世界の麻酔薬市場について調査し、市場の概要とともに、薬剤クラス別、投与経路別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

市場リーダートップ5の競合マトリックス
参入企業トップ5のSWOT分析
市場の主要企業トップ10の情勢
- Baxter International Inc.
- AstraZeneca plc
- AbbVie Inc.
- B. Braun Melsungen AG
- Fresenius SE & Co. KgaA
- Hospira Inc.
- Pfizer Inc.
- Aspen Pharmacare Holdings Limited
- Hikama Pharmaceuticals plc
- Novartis AG

第19章戦略的提言

第20章調査会社について・免責事項

図表

List of Tables

Table 1. Competition Matrix of Top 5 Market Leaders
Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 2. Global Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 3. Global Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 4. Global Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 5. Global Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 6. Global Anesthesia Drugs Market Share (%), By Region, 2018-2032Fs
Figure 7. North America Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 8. North America Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 9. North America Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 10. North America Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 11. North America Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 12. North America Anesthesia Drugs Market Share (%), By Country, 2018-2032F
Figure 13. United States Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 14. United States Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 15. United States Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 16. United States Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 17. United States Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 18. Canada Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 19. Canada Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 20. Canada Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 21. Canada Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 22. Canada Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 23. Mexico Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 24. Mexico Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 25. Mexico Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 26. Mexico Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 27. Mexico Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 28. Europe Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 29. Europe Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 30. Europe Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 31. Europe Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 32. Europe Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 33. Europe Anesthesia Drugs Market Share (%), By Country, 2018-2032F
Figure 34. Germany Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 35. Germany Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 36. Germany Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 37. Germany Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 38. Germany Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 39. France Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 40. France Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 41. France Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 42. France Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 43. France Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 44. Italy Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 45. Italy Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 46. Italy Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 47. Italy Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 48. Italy Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 49. United Kingdom Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 50. United Kingdom Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 51. United Kingdom Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 52. United Kingdom Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 53. United Kingdom Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 54. Russia Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 55. Russia Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 56. Russia Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 57. Russia Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 58. Russia Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 59. Netherlands Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 60. Netherlands Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 61. Netherlands Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 62. Netherlands Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 63. Netherlands Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 64. Spain Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 65. Spain Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 66. Spain Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 67. Spain Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 68. Spain Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 69. Turkey Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 70. Turkey Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 71. Turkey Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 72. Turkey Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 73. Turkey Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 74. Poland Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 75. Poland Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 76. Poland Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 77. Poland Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 78. Poland Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 79. South America Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 80. South America Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 81. South America Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 82. South America Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 83. South America Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 84. South America Anesthesia Drugs Market Share (%), By Country, 2018-2032F
Figure 85. Brazil Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 86. Brazil Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 87. Brazil Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 88. Brazil Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 89. Brazil Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 90. Argentina Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 91. Argentina Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 92. Argentina Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 93. Argentina Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 94. Argentina Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 95. Asia-Pacific Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 96. Asia-Pacific Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 97. Asia-Pacific Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 98. Asia-Pacific Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 99. Asia-Pacific Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 100. Asia-Pacific Anesthesia Drugs Market Share (%), By Country, 2018-2032F
Figure 101. India Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 102. India Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 103. India Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 104. India Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 105. India Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 106. China Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 107. China Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 108. China Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 109. China Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 110. China Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 111. Japan Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 112. Japan Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 113. Japan Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 114. Japan Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 115. Japan Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 116. Australia Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 117. Australia Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 118. Australia Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 119. Australia Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 120. Australia Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 121. Vietnam Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 122. Vietnam Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 123. Vietnam Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 124. Vietnam Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 125. Vietnam Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 126. South Korea Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 127. South Korea Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 128. South Korea Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 129. South Korea Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 130. South Korea Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 131. Indonesia Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 132. Indonesia Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 133. Indonesia Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 134. Indonesia Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 135. Indonesia Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 136. Philippines Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 137. Philippines Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 138. Philippines Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 139. Philippines Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 140. Philippines Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 141. Middle East & Africa Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 142. Middle East & Africa Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 143. Middle East & Africa Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 144. Middle East & Africa Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 145. Middle East & Africa Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 146. Middle East & Africa Anesthesia Drugs Market Share (%), By Country, 2018-2032F
Figure 147. Saudi Arabia Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 148. Saudi Arabia Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 149. Saudi Arabia Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 150. Saudi Arabia Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 151. Saudi Arabia Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 152. UAE Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 153. UAE Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 154. UAE Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 155. UAE Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 156. UAE Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 157. South Africa Anesthesia Drugs Market, By Value, In USD Billion, 2018-2032F
Figure 158. South Africa Anesthesia Drugs Market Share (%), By Drugs Class, 2018-2032F
Figure 159. South Africa Anesthesia Drugs Market Share (%), By Route of Administration, 2018-2032F
Figure 160. South Africa Anesthesia Drugs Market Share (%), By Application, 2018-2032F
Figure 161. South Africa Anesthesia Drugs Market Share (%), By End-user, 2018-2032F
Figure 162. By Drugs Class Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 163. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 164. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Product Code: MX12961

Global anesthesia drugs market is projected to witness a CAGR of 4.73% during the forecast period 2025-2032, growing from USD 7.71 billion in 2024 to USD 11.16 billion in 2032. The market's growth can be attributed to the rising cases of chronic diseases, increasing reliance on surgical procedures, and the expansion of the aging population. The World Health Organization (WHO) estimates that cardiovascular diseases are the leading cause of death and claim approximately 17.9 million lives every year.

From elective cosmetic surgeries to complex organ transplants, almost all procedures call for anesthesia to maintain patient safety and comfort during the procedure. With the ever-rising cases of chronic and lifestyle diseases, the number of surgeries is expected to increase significantly in the coming years. The elderly population around the world further supports this trend; elderly patients often require surgical care for degenerative conditions such as osteoarthritis, cataracts, and cardiovascular disorders, among others.

Hospitals and outpatient surgery centers are witnessing a rise in both inpatient and daycare surgeries, thereby sustaining the demand for general, regional, and local anesthetics. Technological advancements, including integrated anesthesia delivery systems and real-time patient monitoring, are improving the precision and safety of anesthesia drug delivery during procedures.

Increasing Prevalence of Chronic Diseases Boosts Market Demand

The rising numbers of chronic diseases are significantly driving the growth of the anesthesia drugs market. Chronic conditions such as cardiovascular diseases, diabetes, cancer, and obesity often require surgical intervention for treatment or disease management. As per the estimates of the World Obesity Federation, more than one billion people across the globe were living with obesity in 2024. With the rising burden of such diseases, there is an increase in demand for anesthesia drugs. Among the several interventions required for cardiovascular diseases, bypass surgeries and angioplasties depend on anesthesia for patient safety and comfort. Similarly, various orthopedic procedures also rely on anesthesia drugs in cases where surgeries are essential.

Meanwhile, advancements in medical technology have increased the safety and accessibility of surgeries to patients who might otherwise not undergo the procedure. This has led to an increase in demand for general and local anesthetics, depending on the requirements of the procedure and the patient population.

Novel Launches by Key Players Support Market Expansion

The recent introduction of new anesthesia drugs and formulations is facilitating the safety, efficacy, and convenience in the administration of anesthesia. For instance, in February 2024, Hikama Pharmaceuticals plc introduced Fentanyl Citrate Injection, USP, in prefilled syringes in the United States. The product is designed for short-duration analgesic use during anesthetic periods, including pre-medication, induction, maintenance, and postoperative recovery. It can also serve as a narcotic analgesic supplement in general or regional anesthesia and as an anesthetic agent with oxygen for high-risk patients undergoing complex procedures such as open-heart surgeries. With this launch, the company aims to enhance patient care by providing new dosage forms and expanding the choice of essential medicines available to hospitals and patients.

These launches are supported by ongoing research and development activities that focus on creating ultra-short-acting anesthetics and advanced delivery systems. The introduction of innovative products aids in improving patient outcomes while expanding the scope of surgical procedures that can be performed under general anesthesia.

Knee and Hip Replacements Dominate the Market

The segment's growth is supported by the increasing prevalence of osteoarthritis in various regions across the globe, rapid expansion of the aging population, and advancements in surgical techniques. The World Health Organization (WHO) estimates that one in six individuals across the globe will be sixty or older by 2030. The dominance of this segment in the market is also supported by favorable reimbursement policies and robust healthcare infrastructure in regions like North America, which holds a significant share of the global anesthesia drugs market.

Meanwhile, cancer is anticipated to witness the fastest growth in the coming years as the number of people affected by cancer increases due to increasing exposure to known risk factors. Types of cancer, such as breast cancer and lung cancer, require surgical intervention for effectively combating the condition and thus require general anesthesia.

North America Holds Major Market Share

The growth of the anesthesia drugs market in North America can be attributed to the rising prevalence of various chronic diseases and disorders, strong presence of leading pharmaceutical companies and a well-developed healthcare sector, and continuous emphasis on technological innovations. The increasing cases of conditions, including cancer and cardiovascular diseases, among others, that often require surgical intervention for appropriately treating the condition are bolstering the market's demand. The American Cancer Society estimates that approximately 2,041,910 new cancer cases will be reported in the United States in 2025. Additionally, the rising demand for minimally invasive surgeries and cosmetic procedures, which often involve anesthesia, is also contributing significantly to the market's expansion. Furthermore, advancements in anesthesia technology, such as safer anesthetic agents and administration, enhance patient safety and comfort, further boosting the market's demand. The market is also influenced by regulatory support and educational initiatives that emphasize safe anesthesia practices. For instance, organizations such as the American Association of Nurse Anesthesiologists promote awareness about the importance of safe dental anesthesia care, among others.

Future Market Scenario (2025 - 2032F)

The market is anticipated to see a gradual rise in demand due to an increasing number of surgeries, upgradation of healthcare infrastructure in different regions across the globe, and rising awareness about advanced anesthesia techniques. The transition to outpatient surgeries, along with increasing implementation of pain-free surgery, is further expected to accelerate the demand for faster and specific anesthetics. In addition, the market is also expected to benefit from AI drug delivery device development as well as innovations that focus on green anesthesia, intended to reduce the negative environmental impacts of anesthesia drugs. Furthermore, the rapid expansion of the aging population is also expected to bolster the market's demand as the older population is more susceptible to different diseases, disorders, and injuries.

Key Players Landscape and Outlook

The key players of the market are focusing on expanding their market presence in different regions across the globe by enhancing their product portfolios. For instance, in April 2024, Baxter International Inc. announced the expansion of its pharma portfolio with the launch of five injectables in the United States. The products launched by the company include norepinephrine bitartrate in 5% dextrose injection, vasopressin in 0.9% sodium chloride injection, vancomycin injection, USP, ropivacaine hydrochloride injection, USP, and regadenoson injection pre-filled syringe. The availability of these products addresses the unmet requirements of the patient population in key therapeutic areas. Thus, this expansion meets the increasing demand for safe and effective anesthesia solutions, driving the market's expansion.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Anesthesia Drugs Market Outlook, 2018-2032F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
4.2. Market Share Analysis & Forecast
- 4.2.1. By Drugs Class
  - 4.2.1.1. Sevoflurane
  - 4.2.1.2. Propofol
  - 4.2.1.3. Dexmedetomidine
  - 4.2.1.4. Remifentanil
  - 4.2.1.5. Desflurane
  - 4.2.1.6. Midazolam
  - 4.2.1.7. Others
- 4.2.2. By Route of Administration
  - 4.2.2.1. Intravenous
  - 4.2.2.2. Inhaled
- 4.2.3. By Application
  - 4.2.3.1. Heart Surgeries
  - 4.2.3.2. Cancer
  - 4.2.3.3. General Surgery
  - 4.2.3.4. Knee and Hip Replacements
  - 4.2.3.5. Others
- 4.2.4. By End-user
  - 4.2.4.1. Hospitals
  - 4.2.4.2. Ambulatory Surgical Centers
  - 4.2.4.3. Others
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia-Pacific
  - 4.2.5.4. South America
  - 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
4.3. Market Map Analysis, 2024
- 4.3.1. By Drugs Class
- 4.3.2. By Route of Administration
- 4.3.3. By Application
- 4.3.4. By End-user
- 4.3.5. By Region

5. North America Anesthesia Drugs Market Outlook, 2018-2032F

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Drugs Class
  - 5.2.1.1. Sevoflurane
  - 5.2.1.2. Propofol
  - 5.2.1.3. Dexmedetomidine
  - 5.2.1.4. Remifentanil
  - 5.2.1.5. Desflurane
  - 5.2.1.6. Midazolam
  - 5.2.1.7. Others
- 5.2.2. By Route of Administration
  - 5.2.2.1. Intravenous
  - 5.2.2.2. Inhaled
- 5.2.3. By Application
  - 5.2.3.1. Heart Surgeries
  - 5.2.3.2. Cancer
  - 5.2.3.3. General Surgery
  - 5.2.3.4. Knee and Hip Replacements
  - 5.2.3.5. Others
- 5.2.4. By End-user
  - 5.2.4.1. Hospitals
  - 5.2.4.2. Ambulatory Surgical Centers
  - 5.2.4.3. Others
- 5.2.5. By Country Share
  - 5.2.5.1. United States
  - 5.2.5.2. Canada
  - 5.2.5.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Anesthesia Drugs Market Outlook, 2018-2032F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Drugs Class
      - 5.3.1.2.1.1. Sevoflurane
      - 5.3.1.2.1.2. Propofol
      - 5.3.1.2.1.3. Dexmedetomidine
      - 5.3.1.2.1.4. Remifentanil
      - 5.3.1.2.1.5. Desflurane
      - 5.3.1.2.1.6. Midazolam
      - 5.3.1.2.1.7. Others
    - 5.3.1.2.2. By Route of Administration
      - 5.3.1.2.2.1. Intravenous
      - 5.3.1.2.2.2. Inhaled
    - 5.3.1.2.3. By Application
      - 5.3.1.2.3.1. Heart Surgeries
      - 5.3.1.2.3.2. Cancer
      - 5.3.1.2.3.3. General Surgery
      - 5.3.1.2.3.4. Knee and Hip Replacements
      - 5.3.1.2.3.5. Others
    - 5.3.1.2.4. By End-user
      - 5.3.1.2.4.1. Hospitals
      - 5.3.1.2.4.2. Ambulatory Surgical Centers
      - 5.3.1.2.4.3. Others
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Anesthesia Drugs Market Outlook, 2018-2032F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Turkey
6.9. Poland

7. Asia-Pacific Anesthesia Drugs Market Outlook, 2018-2032F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Anesthesia Drugs Market Outlook, 2018-2032F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Anesthesia Drugs Market Outlook, 2018-2032F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

15.1. Market Drivers
15.2. Market Challenges

16. Market Trends and Developments

17. Clinical Trial Overview

18. Competitive Landscape

18.1. Competition Matrix of Top 5 Market Leaders
18.2. SWOT Analysis for Top 5 Players
18.3. Key Players Landscape for Top 10 Market Players
- 18.3.1. Baxter International Inc.
  - 18.3.1.1. Company Details
  - 18.3.1.2. Key Management Personnel
  - 18.3.1.3. Products and Services
  - 18.3.1.4. Financials (As Reported)
  - 18.3.1.5. Key Market Focus and Geographical Presence
  - 18.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 18.3.2. AstraZeneca plc
- 18.3.3. AbbVie Inc.
- 18.3.4. B. Braun Melsungen AG
- 18.3.5. Fresenius SE & Co. KgaA
- 18.3.6. Hospira Inc.
- 18.3.7. Pfizer Inc.
- 18.3.8. Aspen Pharmacare Holdings Limited
- 18.3.9. Hikama Pharmaceuticals plc
- 18.3.10. Novartis AG

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

麻酔薬の世界市場：薬剤クラス別、投与経路別、用途別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Anesthesia Drugs Market Assessment, By Drugs Class, By Route of Administration, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の麻酔薬市場の見通し、2018年～2032年

第5章 北米の麻酔薬市場の見通し、2018年～2032年

第6章 欧州の麻酔薬市場の見通し、2018年～2032年

第7章 アジア太平洋の麻酔薬市場の見通し、2018年～2032年

第8章 南米の麻酔薬市場の見通し、2018年～2032年

第9章 中東・アフリカの麻酔薬市場の見通し、2018年～2032年

第10章 需要供給分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 PESTLE分析

第14章 価格分析

第15章 市場力学

第16章 市場動向と発展

第17章 臨床試験の概要

第18章 競合情勢

第19章 戦略的提言

第20章 調査会社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Anesthesia Drugs Market Outlook, 2018-2032F

5. North America Anesthesia Drugs Market Outlook, 2018-2032F

6. Europe Anesthesia Drugs Market Outlook, 2018-2032F

7. Asia-Pacific Anesthesia Drugs Market Outlook, 2018-2032F

8. South America Anesthesia Drugs Market Outlook, 2018-2032F

9. Middle East and Africa Anesthesia Drugs Market Outlook, 2018-2032F

10. Demand Supply Analysis

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

16. Market Trends and Developments

17. Clinical Trial Overview

18. Competitive Landscape

19. Strategic Recommendations

20. About Us and Disclaimer

第1章プロジェクトの範囲と定義

第2章調査手法

第3章エグゼクティブサマリー

第4章世界の麻酔薬市場の見通し、2018年～2032年

第5章北米の麻酔薬市場の見通し、2018年～2032年

第6章欧州の麻酔薬市場の見通し、2018年～2032年

第7章アジア太平洋の麻酔薬市場の見通し、2018年～2032年

第8章南米の麻酔薬市場の見通し、2018年～2032年

第9章中東・アフリカの麻酔薬市場の見通し、2018年～2032年

第10章需要供給分析

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

第14章価格分析

第15章市場力学

第16章市場動向と発展

第17章臨床試験の概要

第18章競合情勢

第19章戦略的提言

第20章調査会社について・免責事項